However, in subsequent patients, grade 3 neutropenia was managed with intermittent granulocyte colony-stimulating factor (5 μg/kg subcutaneous injection once or twice per week) without crizotinib dose reduction. This evidence concerns the gene CSF3 and Decreased total neutrophil count.